Cutaneous Squamous Cell Carcinoma of the Head and Neck

• CLINICAL_TRIALS trial_result · 2026-04-16
  Clinical Trial Update: Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy [Phase 2]

  Phase 2 trial evaluating pain management regimens using gabapentin, methadone, and oxycodone with or without venlafaxine in patients with cu…

• CLINICAL_TRIALS trial_result · 2026-03-09
  Clinical Trial Update: Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

  A Johns Hopkins University-sponsored clinical trial investigating surveillance of regional nodal basins in high-risk cutaneous squamous cell…

• CLINICAL_TRIALS trial_result · 2025-11-19
  Clinical Trial Update: Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition [Phase 2]

  Phase 2 trial evaluating quad-shot radiotherapy in combination with an immune checkpoint inhibitor for advanced and recurrent head and neck …

• CLINICAL_TRIALS trial_result · 2023-09-05
  Clinical Trial Update: Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site [Phase 2]

  Phase 2 trial update evaluating atezolizumab before surgery in regionally metastatic head and neck cutaneous squamous cell carcinoma; the st…

• CLINICAL_TRIALS trial_result · 2022-07-14
  Clinical Trial Update: Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC [Phase 2]

  Phase 2 trial of cemiplimab-rwlc for unresectable locally recurrent and/or metastatic cutaneous squamous cell carcinoma has terminated with …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-05-10
  Clinical Trial Update: Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck [Phase 2]

  Phase 2 trial assessing postoperative radiation with cetuximab for locally advanced cutaneous squamous cell carcinoma of the head and neck c…